Cargando…
Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy
Hepatic encephalopathy is a complex disease entity ranging from mild cognitive dysfunction to deep coma. Traditionally, treatment has focused on a reduction of ammonia through a reduced production, absorption, or clearance. Rifaximin is a nonabsorbable antibiotic, which reduces the production of amm...
Autores principales: | Kimer, Nina, Krag, Aleksander, Gluud, Lise L |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3964161/ https://www.ncbi.nlm.nih.gov/pubmed/24672227 http://dx.doi.org/10.2147/PPA.S41565 |
Ejemplares similares
-
Antiviral therapy for prevention of hepatocellular carcinoma in chronic
hepatitis C: systematic review and meta-analysis of randomised controlled
trials
por: Kimer, Nina, et al.
Publicado: (2012) -
Rifaximin in the treatment of hepatic encephalopathy
por: Iadevaia, Maddalena Diana, et al.
Publicado: (2011) -
Combination of rifaximin and lactulose improves clinical efficacy and mortality in patients with hepatic encephalopathy
por: Wang, Zhida, et al.
Publicado: (2018) -
Efficacy and Safety of Rifaximin in the Prevention of Recurrent Episodes of Hepatic Encephalopathy: A Systematic Review and Meta-analysis
por: Elmoursi, Ahmed, et al.
Publicado: (2023) -
Rifaximin, Microbiota Biology, and Hepatic Encephalopathy
por: Peleman, Cedric, et al.
Publicado: (2016)